The global diabetic ketoacidosis treatment market, valued at USD 864.63 million in 2024, is projected to reach USD 1,292.08 million by 2034, growing at a CAGR of 4.1% from 2025 to 2034. With the continued rise in diabetes-related complications, healthcare systems worldwide are increasing their focus on early detection and aggressive management of DKA—a...